News Conference News AHA 2014 Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 Long-Term Better than Short-Term Prasugrel After PES Stenting November 15, 2014
News Conference News AHA 2014 ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders Yael L. Maxwell November 15, 2014
News Conference News AHA 2014 ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months November 15, 2014
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Conference News AHA 2012 Platelet Reactivity in Response to Prasugrel Depends on the Test November 04, 2012
News Conference News AHA 2012 ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients Jason Kahn November 04, 2012
News Conference News Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes November 16, 2011
News Conference News ‘Judicious Use’ of DES in Low-Risk Patients Could Save Over $200 Million per Year November 16, 2011
News Conference News PRISM Individualized Informed Consent Improves PCI Choice, Experience November 14, 2011
News Conference News AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab November 13, 2011